Literature DB >> 25550305

Prevalence of Symptoms and Quality of Life Among Jordanian Cancer Patients.

Mohammad Al Qadire1, Murad Al Khalaileh2.   

Abstract

In Jordan, little is known about cancer-related symptoms prevalence, severity, and its impacts on patients' quality of life. Therefore, this study was conducted to estimate cancer-related symptoms prevalence, severity, and predictors of quality of life of cancer patients in Jordan. A descriptive cross-sectional survey design was used. The sample consisted of 498 Jordanian cancer patients. There were slightly more males (51.6%) and a mean age of 44.3 (SD = 15.3) years. The mean of the number of symptoms reported by patients was 11 (SD = 3.3). The most prevalent symptoms were fatigue (92.5%), feeling drowsy (87.1%), lack of appetite (86.3%), being distressed (86.1%), and pain (85.5%). Furthermore, Jordanian cancer patients had low mean total scores for quality of life at a level of 18.5 (SD = 4.9). A comprehensive palliative care program is recommended, led by a representative from the Ministry of Health, to integrate palliative care within the current health care system in Jordan.
© The Author(s) 2014.

Entities:  

Keywords:  Jordan; adult; cancer; palliative care; prevalence; quality of life; symptoms management

Mesh:

Year:  2014        PMID: 25550305     DOI: 10.1177/1054773814564212

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  8 in total

1.  Cancer Pain Management at Oncology Units: Comparing Knowledge, Attitudes and Perceived Barriers Between Physicians and Nurses.

Authors:  Muhammad Darawad; Malek Khalel Alnajar; Maysoon S Abdalrahim; Aqel Mohammad El-Aqoul
Journal:  J Cancer Educ       Date:  2019-04       Impact factor: 2.037

2.  The Impact of VR-CALM Intervention Based on VR on Psychological Distress and Symptom Management in Breast Cancer Survivors.

Authors:  Xiuqing Zhang; Senbang Yao; Menglian Wang; Xiangxiang Yin; Ziran Bi; Yanyan Jing; Huaidong Cheng
Journal:  J Oncol       Date:  2022-06-07       Impact factor: 4.501

3.  Analysis of the unmet needs of Palestinian advanced cancer patients and their relationship to emotional distress: results from a cross-sectional study.

Authors:  Hammoda Abu-Odah; Alex Molassiotis; Justina Yat Wa Liu
Journal:  BMC Palliat Care       Date:  2022-05-14       Impact factor: 3.113

4.  Prevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study.

Authors:  Chun Li Liu; Li Liu; Yi Zhang; Xiao Ze Dai; Hui Wu
Journal:  Health Qual Life Outcomes       Date:  2017-08-17       Impact factor: 3.186

Review 5.  Palliative Care and the Management of Common Distressing Symptoms in Advanced Cancer: Pain, Breathlessness, Nausea and Vomiting, and Fatigue.

Authors:  Lesley A Henson; Matthew Maddocks; Catherine Evans; Martin Davidson; Stephanie Hicks; Irene J Higginson
Journal:  J Clin Oncol       Date:  2020-02-05       Impact factor: 44.544

6.  Knowledge, Practices, and Perceived Barriers in Cancer Pain Management at Oncology Units: A Cross-Sectional Survey of Medical Staff in China.

Authors:  Zaoqin Yu; Wei Li; Xiaofang Shangguan; Yuanxuan Cai; Qianyan Gao; Ximin Wang; Yuan Chen; Dong Liu; Chengliang Zhang
Journal:  J Pain Res       Date:  2022-01-21       Impact factor: 3.133

7.  Knowledge, practice and perceived barriers towards chemotherapy induced nausea and vomiting in prophylaxis guideline adherence among nurses in oncology units at selected hospitals, in Addis Ababa, Ethiopia, a cross-sectional study.

Authors:  Deneke Gebre; Rajalakshmi Murugan; Ketema Bizuwork; Teshome Habte Wurjine
Journal:  BMC Nurs       Date:  2022-08-11

8.  Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study.

Authors:  Oscar Corli; Giacomo Pellegrini; Cristina Bosetti; Luca Riva; Matteo Crippa; Emanuele Amodio; Gianlorenzo Scaccabarozzi
Journal:  Int J Environ Res Public Health       Date:  2020-11-14       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.